Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Luigino Calzetta, Beatrice Ludovica Ritondo, Maria Gabriella Matera, Gabriella Pezzuto, Mario Cazzola & Paola Rogliani. (2020) Investigational treatments in phase I and II clinical trials: a systematic review in chronic obstructive pulmonary disease (COPD). Expert Opinion on Investigational Drugs 29:7, pages 723-738.
Read now
Read now
Rongchang Chen, Nanshan Zhong, Hao-Yan Wang, Li Zhao, Xiaodong Mei, Zhiqiang Qin, Juan Huang, Pryseley N Assam, Andrea Maes, Shahid Siddiqui, Ubaldo J Martin & Colin Reisner. (2020) Efficacy And Safety Of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (GFF MDI) Formulated Using Co-Suspension Delivery Technology In Chinese Patients With COPD. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 43-56.
Read now
Read now
Articles from other publishers (6)
Satoru Inoue, Soniya Vaidya, Hanns-Christian Tillmann, Yohei Sakita, Surendra Machineni, Olivier Heudi & Kenichi Furihata. (2021) Pharmacokinetics of indacaterol, glycopyrronium and mometasone furoate administered as an inhaled fixed-dose combination in Japanese and Caucasian healthy subjects. BMC Pulmonary Medicine 21:1.
Crossref
Crossref
Yasuhiro Gon, Koichi Nishi, Kazuhiro Sato, Andrea Maes, Shahid Siddiqui, Nobuya Hayashi, Hajime Hirata, Ubaldo J. Martin & Colin Reisner. (2021) Efficacy and safety of glycopyrrolate/formoterol fumarate metered dose inhaler delivered using co-suspension delivery technology in Japanese patients with moderate-to-very severe chronic obstructive pulmonary disease. Respiratory Investigation 59:1, pages 135-144.
Crossref
Crossref
Chin Kook Rhee, Hajime Yoshisue & Rahul Lad. (2019) Fixed-Dose Combinations of Long-Acting Bronchodilators for the Management of COPD: Global and Asian Perspectives. Advances in Therapy 36:3, pages 495-519.
Crossref
Crossref
Toshio Nakaki. 2019. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions
151
161
.
Colin Reisner, Joel Miller, Paolo DePetrillo, Andrea Maes, Shahid Siddiqui & Ubaldo J. Martin. (2018) Pharmacokinetics and safety of a single dose of the novel LAMA/LABA fixed-dose combination of glycopyrronium/formoterol fumarate dihydrate metered dose inhaler, formulated using co-suspension delivery technology, in Japanese healthy subjects. Pulmonary Pharmacology & Therapeutics 53, pages 33-38.
Crossref
Crossref
Paul Dorinsky, Paolo DePetrillo, Shahid Siddiqui, Andrea Maes & Colin Reisner. (2018) Safety and pharmacokinetics of budesonide/glycopyrronium/formoterol fumarate dihydrate metered dose inhaler (BGF MDI) in healthy adult subjects of Japanese descent. Pulmonary Pharmacology & Therapeutics 51, pages 18-25.
Crossref
Crossref